Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2015-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d105d6e4dff562ce5e8932fcb9b83ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b53b8062794b1011f166b8d17dd50226 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_583adf86336abcee81d87892591ad822 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0733009f8f9a5ca1a98ec67cc0a81a8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0de59d9e092d48dbac7dd7bbc7f0457 |
publicationDate |
2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2015281155-B9 |
titleOfInvention |
Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on NAE inhibitory effect |
abstract |
The problem to be solved by the present invention is to provide a novel pyrrolopyrimidine compound or a salt thereof having an NAE inhibitory effect as well as a cell growth-suppressing effect. The present invention provides a compound represented by general formula (A) or a salt thereof, and a NAE inhibitor, pharmaceutical composition, and antitumor agent having this compound or a salt thereof as an active ingredient. |
priorityDate |
2014-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |